Press Releases
January 28, 2025
Instylla Announces FDA Clearance of Tembo™ Embolic System
BEDFORD, Mass., Jan. 28, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo™ Embolic
